Wegovy 0.25 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE668
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,708
Award facts
- Contract value 100% obligated
- $18,707.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $18,707.82, awards pharmaceutical supplies to AmerisourceBergen Drug Corp for delivery of Wegovy (semaglutide) 0.25 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, performed at the contractor's Conshohocken, Pennsylvania facility. The Defense Logistics Agency (DLA), which serves as the funding federal agency, issued this non-set-aside award through competitive procurement, reflecting the agency's need to supply diabetes and weight management medications to military healthcare systems.
This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC vehicle worth up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support mechanism enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its role as a critical vendor for military and veteran healthcare systems, with the capability to efficiently fulfill government procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FE668?
SPE2DR26FE668 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FE668 worth?
The government has obligated $18,708 on SPE2DR26FE668.
Is contract SPE2DR26FE668 an order under another contract?
Yes. SPE2DR26FE668 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE668 competed?
The extent of competition for SPE2DR26FE668 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award